Intended audience is for UK HCPs
Tagrisso® (Osimertinib) Connect –
New Content Coming Soon
Adverse events should be reported. Reporting forms and information can be found at http://yellowcard.mhra.gov.uk/ or
search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033.